BACKGROUND: Prior studies have demonstrated increased adherence of sickle cell erythrocytes to vascular endothelial cells. While decreased production of nitric oxide and increased production of adhesion molecules have been implicated in this pathophysiology, the relative contribution of these mechanisms during acute sickle cell crises as compared to steady state conditions have not been elucidated. METHODS AND RESULTS: We studied 10 consecutive young adult patients presenting with a sickle cell crisis. Endothelial function was evaluated by a non-invasive brachial artery shear stress method. Serum levels of adhesion molecules were obtained during the crisis. Both brachial artery responsiveness and serum levels of adhesion molecules were then repeated at steady state. Ten age and gender matched volunteers served as a control group. Impaired endothelial function and impaired endothelium-independent vasodilatation were observed in all sickle cell patients during both steady state and during crisis. Flow mediated dilation (FMD)% was 3.25+/- 2.76% during crisis, 4.57+/- 4.11 at steady state, compared with the control group FMD of 11.64+/- 7.69% (p< 0.001). Flow independent dilation was 10.35+/- 11.3% during crisis, 10.03+/- 6.52% at steady state, compared with control group FID of 24.17+/- 11.87% (p< 0.001). Levels of cell adhesion molecules and markers of inflammation were increased in sickle cell crisis patients compared with the control group: sCD40 ligand levels during the acute crisis were over twice the level of normal matched volunteers (p=0.02), and similarly significant increases were seen for E-selectin (p=0.008), ICAM-1 (p=0.037) and VCAM-1 levels (p=0.01). The levels of each of these biomarkers was not significantly increased during acute crises as compared to patients' recovery state. CONCLUSIONS: Sickle cell anemia patients have severe systemic endothelial dysfunction as demonstrated by both brachial artery assessment and increased serum levels of adhesion molecules. These abnormalities characterize not only the sickle cell crisis but also the steady state pathophysiology of sickle cell anemia.
BACKGROUND: Prior studies have demonstrated increased adherence of sickle cell erythrocytes to vascular endothelial cells. While decreased production of nitric oxide and increased production of adhesion molecules have been implicated in this pathophysiology, the relative contribution of these mechanisms during acute sickle cell crises as compared to steady state conditions have not been elucidated. METHODS AND RESULTS: We studied 10 consecutive young adult patients presenting with a sickle cell crisis. Endothelial function was evaluated by a non-invasive brachial artery shear stress method. Serum levels of adhesion molecules were obtained during the crisis. Both brachial artery responsiveness and serum levels of adhesion molecules were then repeated at steady state. Ten age and gender matched volunteers served as a control group. Impaired endothelial function and impaired endothelium-independent vasodilatation were observed in all sickle cell patients during both steady state and during crisis. Flow mediated dilation (FMD)% was 3.25+/- 2.76% during crisis, 4.57+/- 4.11 at steady state, compared with the control group FMD of 11.64+/- 7.69% (p< 0.001). Flow independent dilation was 10.35+/- 11.3% during crisis, 10.03+/- 6.52% at steady state, compared with control group FID of 24.17+/- 11.87% (p< 0.001). Levels of cell adhesion molecules and markers of inflammation were increased in sickle cell crisis patients compared with the control group: sCD40 ligand levels during the acute crisis were over twice the level of normal matched volunteers (p=0.02), and similarly significant increases were seen for E-selectin (p=0.008), ICAM-1 (p=0.037) and VCAM-1 levels (p=0.01). The levels of each of these biomarkers was not significantly increased during acute crises as compared to patients' recovery state. CONCLUSIONS:Sickle cell anemiapatients have severe systemic endothelial dysfunction as demonstrated by both brachial artery assessment and increased serum levels of adhesion molecules. These abnormalities characterize not only the sickle cell crisis but also the steady state pathophysiology of sickle cell anemia.
Authors: L Belhassen; G Pelle; S Sediame; D Bachir; C Carville; C Bucherer; C Lacombe; F Galacteros; S Adnot Journal: Blood Date: 2001-03-15 Impact factor: 22.113
Authors: Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin Journal: Nat Med Date: 2002-11-11 Impact factor: 53.440
Authors: Mark T Gladwin; Alan N Schechter; Frederick P Ognibene; Wynona A Coles; Christopher D Reiter; William H Schenke; Gyorgy Csako; Myron A Waclawiw; Julio A Panza; Richard O Cannon Journal: Circulation Date: 2003-01-21 Impact factor: 29.690
Authors: D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield Journal: Lancet Date: 1992-11-07 Impact factor: 79.321
Authors: Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene Journal: N Engl J Med Date: 2004-02-26 Impact factor: 91.245
Authors: Biree Andemariam; Alexander J Adami; Anurag Singh; Jeffrey T McNamara; Eric R Secor; Linda A Guernsey; Roger S Thrall Journal: Transl Res Date: 2015-03-16 Impact factor: 7.012
Authors: Emmanuil S Hatzipantelis; Zoe Dorothea Pana; N Gombakis; A Taparkou; V Tzimouli; D Kleta; D J Zafeiriou; V Garipidou; F Kanakoudi; M Athanassiou Journal: Int J Hematol Date: 2013-06-27 Impact factor: 2.490
Authors: Md Nasimuzzaman; Paritha I Arumugam; Eric S Mullins; Jeanne M James; Katherine VandenHeuvel; Marilou G Narciso; Maureen A Shaw; Sarah McGraw; Bruce J Aronow; Punam Malik Journal: Blood Adv Date: 2019-05-14
Authors: Jeanne E Hendrickson; Eldad A Hod; Jennifer R Perry; Samit Ghosh; Prasanthi Chappa; Olufolake Adisa; Leslie S Kean; Solomon F Ofori-Acquah; David R Archer; Steven L Spitalnik; James C Zimring Journal: Transfusion Date: 2011-07-25 Impact factor: 3.157
Authors: Roberto F Machado; A Kyle Mack; Sabrina Martyr; Christopher Barnett; Peter Macarthur; Vandana Sachdev; Inez Ernst; Lori A Hunter; Wynona A Coles; James P Nichols; Gregory J Kato; Mark T Gladwin Journal: Br J Haematol Date: 2006-12-08 Impact factor: 6.998
Authors: Jon A Detterich; Roberta Kato; Adam Bush; Patjanaporn Chalacheva; Derek Ponce; Madushka De Zoysa; Payal Shah; Michael C Khoo; Herbert J Meiselman; Thomas D Coates; John C Wood Journal: Am J Hematol Date: 2019-04-19 Impact factor: 10.047
Authors: Paritha I Arumugam; Eric S Mullins; Shiva Kumar Shanmukhappa; Brett P Monia; Anastacia Loberg; Maureen A Shaw; Tilat Rizvi; Janaka Wansapura; Jay L Degen; Punam Malik Journal: Blood Date: 2015-08-18 Impact factor: 22.113
Authors: Robert I Liem; Kasiemobi Onyejekwe; Marie Olszewski; Chisalu Nchekwube; Frank P Zaldivar; Shlomit Radom-Aizik; Mark J Rodeghier; Alexis A Thompson Journal: Br J Haematol Date: 2015-10-12 Impact factor: 6.998